This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Danaher (DHR) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Danaher (DHR) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Danaher (DHR) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 9.62% and 3.65%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Danaher Gears Up to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
DHR's Q3 results are likely to be affected by weakness in the Biotechnology and Life Sciences segment.
Honeywell International Inc. (HON) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Honeywell International (HON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exploring Analyst Estimates for Danaher (DHR) Q3 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Danaher (DHR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
Danaher to Benefit From Business Strength Amid Headwinds
by Zacks Equity Research
DHR stands to benefit from strength in the clinical diagnostics business, Abcam buyout and shareholder-friendly policies. Softness in the Instrument unit remains a concern.
3M Surges 45.6% in Six Months: How Should You Play the Stock?
by Avisekh Bhattacharjee
MMM is strategically positioned, leveraging its strong foothold in several key end markets amid certain challenges.
The Zacks Analyst Blog Highlights McDonald's, Danaher, S&P Global, Twin Disc and Cato
by Zacks Equity Research
McDonald's, Danaher, S&P Global, Twin Disc and Cato are included in this Analyst Blog.
Top Stock Reports for McDonald's, Danaher & S&P Global
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corp. (MCD), Danaher Corp. (DHR) and S&P Global Inc. (SPGI), as well as two micro-cap stocks Twin Disc, Inc. (TWIN) and The Cato Corp. (CATO).
3M Stock Trades Near 52-Week High: How Should Investors Play?
by Avisekh Bhattacharjee
MMM is making strides in electronics, automotive and aerospace, and transportation markets, which makes the stock worth a watch amid certain headwinds.
Here's Why It is Appropriate to Retain Danaher Stock For Now
by Zacks Equity Research
DHR benefits from solid momentum across its Diagnostics segment. However, increasing expenses remain a concern.
HTHIY or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HTHIY vs. DHR: Which Stock Is the Better Value Option?
Why Is Danaher (DHR) Up 2% Since Last Earnings Report?
by Zacks Equity Research
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3M (MMM) Rises 21% in a Month: Is the Stock Worth Buying?
by Avisekh Bhattacharjee
3M's (MMM) strong prospects, driven by strength across its businesses and restructuring actions, make it an attractive pick for investors.
Danaher (DHR) Benefits From Business Strength Amid Risks
by Zacks Equity Research
Danaher (DHR) benefits from strength in the clinical diagnostics business, Abcam buyout and pro-investor policies. However, softness in its Instrument unit is concerning.
Markel's (MKL) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Markel's (MKL) Q2 results reflect improvement in earned premiums and increased net investment income.
The Zacks Analyst Blog Highlights Costco, Danaher, ServiceNow, AMREP and Autoscope
by Zacks Equity Research
Costco, Danaher, ServiceNow, AMREP and Autoscope are included in this Analyst Blog.
Top Stock Reports for Costco, Danaher & ServiceNow
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corporation (COST), Danaher Corporation (DHR) and ServiceNow, Inc. (NOW), as well as two micro-cap stocks AMREP Corporation (AXR) and Autoscope Technologies Corporation (AATC).
3M (MMM) Q2 Earnings & Revenues Surpass Estimates, Rise Y/Y
by Zacks Equity Research
3M (MMM) reports y/y adjusted revenue growth of 1.1% in second-quarter 2024 results.
HTHIY or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HTHIY vs. DHR: Which Stock Is the Better Value Option?
3M (MMM) Stock Before Q2 Earnings: To Buy or Not to Buy?
by Avisekh Bhattacharjee
As 3M (MMM) gears up to report second-quarter earnings, let us find out how the expectations stack up and whether it is the right time to buy the stock.
Company News for Jul 24, 2024
by Zacks Equity Research
Companies in The News Are: DHR, GM, PM, ARE
Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y
by Zacks Equity Research
Danaher's (DHR) second-quarter earnings and revenues surpass estimates. However, the company's performance reflects a decrease in core sales in the Biotechnology segment.
Here's What Key Metrics Tell Us About Danaher (DHR) Q2 Earnings
by Zacks Equity Research
The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Danaher (DHR) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 9.55% and 2.78%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?